Spatial technologies are enabling new discoveries that advance our understanding of a range of biology, including viral host immune response and the tumor immune microenvironment. This virtual conference brings together research professionals, scientists, and clinicians from around the world to learn about and discuss recent discoveries in spatial biology.
Scientific tracks include:
Full agenda coming soon.
This free online event allows you to participate at the most convenient time for your location:
Europe: 9:00 AM-3:15 PM British Summer Time / 10:00 AM-4:15 PM Central European Time. September 15.
Americas: 11:00 AM-5:15 PM Eastern Time. September 15.
Asia Pacific: 11:00 AM- 5:15 PM Beijing Standard Time. September 16.
Dr. Christopher Mason is an Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction, as well as an affiliate of Memorial Sloan Kettering Cancer Center (MSKCC), Rockefeller University, Harvard Medical School, and Yale Law School. The Mason laboratory develops and deploys new biochemical and computational methods in functional genomics to elucidate the genetic basis of human disease and physiology. We create and deploy novel techniques in next-generation sequencing and algorithms for: tumor evolution, genome evolution, DNA and RNA modifications, and genome/epigenome engineering. We also work closely with NIST/FDA to build international standards for these methods (SEQC2, IMMSA, and Epigenomics QC groups), to ensure clinical-quality genome measurements and editing. We also work with NASA to build integrated molecular portraits of genomes, epigenomes, transcriptomes, and metagenomes for astronauts, which help establish the molecular foundations and genetic defenses for enabling long-term human spaceflight. He has won the NIH's Transformative R01 Award, the NASA Group Achievement Award, the Pershing Square Sohn Cancer Research Alliance Young Investigator award, the Hirschl-Weill-Caulier Career Scientist Award, the Vallee Scholar Award, the CDC Honor Award for Standardization of Clinical Testing, and the WorldQuant Foundation Scholar Award. He was named as one of the "Brilliant Ten" Scientists by Popular Science, featured as a TEDMED speaker, and called "The Genius of Genetics" by 92Y. He has >200 peer-reviewed papers and scholarly works that have been featured on the covers of Nature, Science, Cell, Nature Biotechnology, Nature Microbiology, and Neuron, as well as legal briefs cited by the U.S. District Court and U.S. Supreme Court. Coverage of his work has also appeared on the covers of the Wall Street Journal, New York Times, TIME, The LA Times, and across many media (ABC, NBC, CBS, Fox, CNN, PBS, NASA, NatGeo). He is an inventor on four patents, co-founded five biotechnology start-up companies, and serves as an advisor to many others.
Dr. Karin Pelka is a research fellow of the German Research Foundation and currently performing her postdoctoral training with Dr. Nir Hacohen at the Broad Institute of MIT and Harvard. By combining systems biology approaches with mechanistic studies, she aims to understand the general principles that shape the immunological states of human colorectal cancer. Karin was selected as member of the 2019 BroadIgnite cohort, a program supporting early career scientists working on high-risk, high-reward projects, is the recipient of the first Stand Up To Cancer Peggy Prescott Early Career Scientist Award in Colorectal Cancer Research and a Stand Up To Cancer Phillip A. Sharp Innovation in Collaboration Award. Karin was a scholar of the German National Academic Foundation and received her PhD in 2016 from the University of Bonn where she trained with Dr. Eicke Latz at the Institute of Innate Immunity.
Dr. Robert Schwartz is an Assistant Professor of Medicine and of the Department of Physiology, and Biophysics, and Systems Biology at Weill Cornell Medicine. He completed his Ph.D. in Biomedical Engineering at the University of Minnesota. His thesis work was on the derivation of stem cell derived hepatocytes and in vitro liver model systems. He completed his insternship and residency in Internal Medicine at Washington University in St. Louis/Barnes Jewish Hospital. His fellowship in Gastroenterology and Hepatology with a focus on hepatology was completed at the Brigham and Women's Hospital. He did a postdoc at MIT and his research continued to focus on the development of stem cell derived hepatocytes as a model system to study human liver disease and for clinical therapy. In his own lab at Weill Cornell Medical College he has continued to focus his work on the clinical translation and research applications of stem cell derived hepatocytes and primary human hepatocytes. In recognition of his work, he was an University of Minnesota Doctoral Dissertation Fellow, an AGA Research Scholar, a UEG Rising Scholar, a Bohmfalk Clinical Scholar, and an Irma Hirsch Trust Scholar. He has >50 peer-reviewed papers and scholarly works that have been featured in Nature, Cell, Nature Chemical Biology, Cell Stem Cell, Journal for Clinical Investigation, and Gastroenterology. He is an inventor on three patents.
NanoString Technologies is a leading provider of life science tools for translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 3,200 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx™ Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections. For more information, please visit www.nanostring.com.
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events